Forschung/Studien

Klinische Forschung
Zürich Amyloidosis Registry.

Therapie-Optimierungsstudien
Zur Zeit keine aktiv.

Experimentelle Forschung
The main focus of research at the Institute of Neuropathology – University Hospital Zurich is to elucidate molecular mechanisms underlying prion diseases and other protein misfolding and deposition diseases, including systemic amyloidoses. To this aim, we establish novel preclinical models and apply cutting edge technologies, including robot-assisted high-throughput screenings, genome-editing and next-generation sequencing. The research activities of the Institute rely on a broad network of national and international collaborations.